Atherosclerosis, endothelial dysfunction, metabolic dysfunction-associated steatotic liver disease (MASLD), and diabetic nephropathy which is the main causes of morbidity and mortality in T2D populations, are mostly caused by chronic low-grade inflammation and oxidative stress
Chromium is also historically associated with the glucose tolerance factor (GTF) concept, which describes chromiums contribution to normal glucose metabolism
HIV leads to the dysregulated binding of CCL2 to its receptor, C-C motif chemokine receptor 2 (CCR2), on neurons, astrocytes, and brain microvascular endothelial cells, ultimately leading to the increased permeability of the bloodbrain barrier (BBB) [51]
In a head-to-head comparison trial pitting ALCAR against carnitine, only ALCAR reduced several biomarkers of oxidative stress within the brain, including those for lipid peroxidation, DNA oxidation, and protein oxidation [21]
You're not following that
GLP-1 agonists independently reduce cardiovascular risk